Tran, Tram T <br/><br/>
Pan-Genotypic Hepatitis C Treatment with Glecaprevir and Pibrentasvir for 8 Weeks Resulted in Improved Cardiovascular and Metabolic Outcomes and Stable Renal Function: A Post-Hoc Analysis of Phase 3 Clinical Trials.  [electronic resource] 

 -  Infectious diseases and therapy  Dec 2018 
 - 473-484 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2193-8229 
<br/><br/><label>Standard No.: </label>10.1007/s40121-018-0218-x  doi